Nanotechnology Based Drug Delivery System Of Rivastigmine For The Treatment Of Alzheimer’s Disease. Journal of Pharmaceutical Negative Results, [S. l.], p. 2532–2541, 2022. DOI: 10.47750/pnr.2022.13.S01.298. Disponível em: https://pnrjournal.com/index.php/home/article/view/9456.. Acesso em: 8 jun. 2026.